Canopy Growth Corp Surges To Daily Highs On Constellation Brands Comments

Benjamin A. Smith

The price action in Canopy Growth Corp (TSE:WEED) (NYSE:CGC) (FRA:11L1) has made a dramatic reversal today, owing to comments made by major stakeholder Constellation Brands. The dramatic reversal in fortune is yet another reason why it pays to have a great operating partner at your side.

Reportedly, Constellation Brands made the favorable comments during a 10:30 am EST conference call to discuss surprisingly good quarterly results. While I was not privy to the call, several reports on social media reveal the bullish comments directed Canopy Growth’s way. Here is a sampling of such comments:

Clearly, we can see the effects Constellation’s comments have exerted on the Canopy Growth’s stock price. With shares trading at the day’s lows, the volume spike just after 10:45 EST is clearly evident. The surge helped push prices past the daily and closing highs on an aggregate basis, although there appears to be some giveback as I type.

The bullish comments also put a bid under the entire sector, with the benchmark Horizons Marijuana Life Sciences Index ETF (TSE:HMMJ) rising about two percent on the news. Whether Canopy Growth can sustain the momentum is another story. All major American stock exchanges are moderately weak this morning, paced by NASDAQ which is currently lower by ↓1.56%.

Nevertheless, the optimism elucidated by Constellation Brands is a bullish anecdote for the market, as they believe not just Canopy Growth—but the uptake of cannabis in general—is going faster than anticipated. Coming from a leading transnational beverage conglomerate, these are heady words.

Keep in mind that if Constellation Brands were to exercise all existing and new warrants obtained in its August 15th deal with Canopy Growth, its ownership would exceed 50 percent. Should that occur, a proportional share of Canopy’s income would show up on the parent company’s income statement (STZ), assuring the company of future growth in 2021 and beyond. For an industry struggling to obtain meaningful growth, this is a significant and advantageous benefit.

As the tagline on Canopy Growth’s press releases often says: Here’s to future growth. We couldn’t agree more.

Benjamin A. Smith

Benjamin A. Smith

Ben is a research analyst and capital markets professional with nearly 20 years of experience. His areas of expertise are broad-based, and include extensive knowledge of macro economics, stock/derivative trading, commodity complexes, cryptocurrencies and technical/quant analysis. He also maintains an particular affinity for U.S. politics and the macro-regulatory environment facing...
More Info...

[email protected] |

Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.

Free Newsletter,
Priceless Content.

Be the first to hear from Midas Letter on all things Cannabis.